Heart Failure

This heart failure channel offers news and new technology to treat heart failure. This includes for new innovations to treat congestive heart failure (CHF). The channel includes news on HFpEF and HFrEF. Heart failure occurs when the heart is no longer able to pump as much blood as the body requires. This can lead to enlargement of the heart because the muscle works harder to supply blood, but the pumping is ineffective. This may be due to defects in the myocardium, such as an infarct, or due to structural issues such as severe valve regurgitation. The disease is divided into four New York Heart Association (NYHA) classes. Stage IV heart failure is when the heart is completely failing and requires a heart transplant  or a left ventricular assist device (LVAD).

News | Heart Failure

April 8, 2022 – Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had ...

Home April 08, 2022
Home
News | Heart Failure

April 6, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure ...

Home April 06, 2022
Home
News | Artificial Intelligence

April 6, 2022 – Myocarditis (inflammation of the heart muscle) is usually caused by viruses, such as in Covid-19 disease ...

Home April 06, 2022
Home
News | Heart Failure

April 4, 2022 – Staying well-hydrated may be associated with a reduced risk for developing heart failure, according to ...

Home April 04, 2022
Home
News | Heart Failure

April 4, 2022 – Observational research has suggested that light alcohol consumption may provide heart-related health ...

Home April 04, 2022
Home
News | Heart Failure

April 4, 2022 – Deep in the brain a group of large neurons produce a hormone which prompts our bodies to hold onto more ...

Home April 04, 2022
Home
News | Heart Failure

April 4, 2022 – Impulse Dynamics, a global medical device company dedicated to improving the lives of people with heart ...

Home April 04, 2022
Home
News | ACC

April 3, 2022 — egnite, Inc., an advanced technology digital health company focused on providing artificial intelligence ...

Home April 03, 2022
Home
News | ACC

April 3, 2022 — A new drug shows promise in providing relief to cardiomyopathy patients experiencing shortness of breath ...

Home April 03, 2022
Home
News | Heart Failure

April 3, 2022 — Silence Therapeutics, a leader in the discovery, development and delivery of novel short interfering ...

Home April 03, 2022
Home
News | Heart Failure

April 1, 2022 — A new joint guideline published today from the American College of Cardiology, the American Heart ...

Home April 01, 2022
Home
News | Heart Failure

April 1, 2022 – The activation of the bone marrow appears to play a key role in the origin and development of ...

Home March 31, 2022
Home
News | ACC

April 1, 2022 —  Royal Philips, a global leader in health technology, announced new additions to its innovative ...

Home April 01, 2022
Home
MedWatch, The FDA Safety Information and Adverse Event Reporting Program, announced that Pfizer is recalling Accuretic (quinapril hydrochloride/hydrochlorothiazide) tablets distributed by Pfizer as well as two authorized generics distributed by Greenstone (quinapril HCL and hydrochlorothiazide and quinapril HCl/hydrochlorothiazide) due to the presence of a nitrosamine, N-nitroso-quinapril, above the Acceptable Daily Intake level.
Feature | Cardiovascular Business | By Melinda Taschetta-Millane

Here is what you and your colleagues found to be most interesting in the field of cardiology during the month of March ...

Home March 31, 2022
Home
Subscribe Now